Type II collagen degradation in spontaneous osteoarthritis in C57Bl/6 and BALB/c mice

Arthritis and Rheumatism

Volumn 42, Issue 11, 1999, Pages 2381-2389

  Stoop, Reinout ^a   Van Der Kraan, Peter M ^a   Buma, Pieter ^a   Hollander, Anthony P ^b   Billinghurst, R Clark ^b   Poole, A Robin ^b   Van Den Berg, Wim B ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL DEATH; COLLAGEN DEGRADATION; CONTROLLED STUDY; DISEASE ASSOCIATION; MALE; MOUSE; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL;

ANIMALS; ARTHRITIS; CARTILAGE, ARTICULAR; CELL DEATH; COLLAGEN; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OSTEOARTHRITIS;

EID: 0033513065     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199911)42:11<2381::AID-ANR17>3.0.CO;2-E     Document Type: Article

References (40)

1. Kempson GE, Muir H, Pollard C, Tuke M. The tensile properties of the cartilage of human femoral condyles related to the content of collagen and glycosaminoglycans. Biochim Biophys Acta 1973; 297:456-72.
2. Eyre DR, Weis MA, Moskowitz RW. Cartilage expression of a type II collagen mutation in an inherited form of osteoarthritis associated with a mild chondrodysplasia. J Clin Invest 1991;87: 357-61.
3. Jimenez SA, Dharmavaram RM. Genetic aspects of familial osteoarthritis. Ann Rheum Dis 1994;53:789-97.
4. Loughlin J, Irven C, Athanasou N, Carr A, Sykes B. Differential allelic expression of the type II collagen gene (COL2A1) in osteoarthritic cartilage. Am J Hum Genet 1995;56:1186-93.
5. Fertala A, Ala-kokko L, Wiaderkiewicz R, Prockop DJ. Collagen II containing a Cys substitution for Arg-alpha 1-519-homotrimeric monomers containing the mutation do not assemble into fibrils but alter the self-assembly of the normal protein. J Biol Chem 1997;272:6457-64.
6. Helminen HJ, Kiraly K, Pelttari A, Tammi MI, Vandenberg P, Pereira R, et al. An inbred line of transgenic mice expressing an internally deleted gene for type II procollagen (COL2A1): young mice have a variable phenotype of a chondrodysplasia and older mice have osteoarthritic changes in joints. J Clin Invest 1993;92: 582-95.
7. Dodge GR, Poole AR. Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1. J Clin Invest 1989;83:647-61.
8. Hollander AP, Heathfield TF, Webber C, Iwata Y, Bourne R, Rorabeck C, et al. Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest 1994;93:1722-32.
9. Hollander AP, Pidoux I, Reiner A, Rorabeck C, Bourne R, Poole AR. Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J Clin Invest 1995;96:2859-69.
10. Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 1997;99:1534-45.
11. Murphy G, Hembry RM, Reynolds JJ. Characterization of a specific antiserum to rabbit stromelysin and demonstration of the synthesis of collagenase and stromelysin by stimulated rabbit articular chondrocytes. Coll Rel Res 1986;6:351-63.
12. Cole AA, Chubinskaya S, Schumacher B, Huch K, Cs-Szabo G, Yao J, et al. Chondrocyte matrix metalloproteinase-8 - human articular chondrocytes express neutrophil collagenase. J Biol Chem 1996;271:11023-6.
13. Reboul P, Pelletier JP, Tardif G, Cloutier JM, Martel-Pelletier J. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes - a role in osteoarthritis. J Clin Invest 1996;97:2011-9.
14. Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 1996;97:761-8.
15. Hasty KA, Jeffrey JJ, Hibbs MS, Welgus HG. The collagen substrate specificity of human neutrophil collagenase. J Biol Chem 1987;262:10048-52.
16. Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 1996;97:761-8.
17. Moldovan F, Pelletier J-P, Hambor J, Cloutier J-M, Martel-Pelletier J. Collagenase-3 (matrix metalloprotease 13) is preferentially localized in the deep layer of human arthritic cartilage in situ: in vitro mimicking effect by transforming growth factor β. Arthritis Rheum 1997;40:1653-61.
18. Shlopov BV, Lie W-R, Mainardi CL, Cole AA, Chubinskaya S, Hasty KA. Osteoarthritic lesions: involvement of three different collagenases. Arthritis Rheum 1997;40:2065-74.
19. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997;272: 2446-51.
20. Kempson GE, Tuke MA, Dingle JT, Barrett AJ, Horsfield PH. The effects of proteolytic enzymes on the mechanical properties of adult human articular cartilage. Biochim Biophys Acta 1976;428: 741-60.
21. Maroudas A. Balance between swelling pressure and collagen tension in normal and degenerate cartilage. Nature 1976;260: 808-9.
22. Setton LA, Mow VC, Muller FJ, Pita JC, Howell DS. Mechanical properties of canine articular cartilage are significantly altered following transection of the anterior cruciate ligament. J Orthop Res 1994;12:451-63.
23. Sah RL, Yang AS, Chen AC, Hant JJ, Halili RB, Yoshioka M, et al. Physical properties of rabbit articular cartilage after transection of the anterior cruciate ligament. J Orthop Res 1997;15:197-203.
24. Chayen J, Bitensky L, Chambers MG. Modulation of murine osteoarthritis. Cell Biochem Funct 1996;14:57-61.
25. Vankemmelbeke M, Dekeyser PM, Hollander AP, Buttle DJ, Demeester J. Characterization of helical cleavages in type II collagen generated by matrixins. Biochem J 1998;330:633-40.
26. Wilhelmi G, Maier R. Beobachtungen über den Einfluß van Druckbelastung und Bewegung auf die Gelenke am Modell arthrosedisponierter Mäuse. Aktuelle Rheumatol 1987;12:161-7.
27. Van Beuningen HM, van der Kraan PM, Arntz OJ, van den Berg WB. Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab Invest 1994;71:279-90.
28. Joosten LB, Lubberts E, Helsen MMA, van den Berg WB. Dual role of IL-12 in early and late stages of murine collagen type II arthritis. J Immunol 1997;159:4094-102.
29. Joosten LAB, Helsen MMA, van de Loo FAJ, van den Berg WB. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFα, anti-IL-1 α/β, and IL-1Ra. Arthritis Rheum 1996;39:797-809.
30. Tonnaer EL, Kuijpers W, Peters TA, Ramaekers FC. Effect of EDTA on cytokeratin detection in the inner ear. J Histochem Cytochem 1990;38:1223-7.
31. Campo RD, Betz RR. Loss of proteoglycans during decalcification of fresh metaphyses with disodium ethylenediaminetetraacetate (EDTA). Calcif Tissue Int 1987;41:52-5.
32. Van der Kraan PM, Glansbeek HL, Vitters EL, van den Berg WB. Early elevation of transforming growth factor-beta, decorin, and biglycan mRNA levels during cartilage matrix restoration after mild proteoglycan depletion. J Rheumatol 1997;24:543-9.
33. Hierck BP, Iperen LV, Gittenberger De Groot AC, Poelmann RE. Modified indirect immunodetection allows study of murine tissue with mouse monoclonal antibodies. J Histochem Cytochem 1994; 42:1499-502.
34. Sokoloff L. Natural history of degenerative joint disease in small laboratory animals. I. Pathologic anatomy of degenerative joint disease in mice. Arch Pathol 1956;123:118-28.
35. Mitchell NS, Shepard N. Changes in proteoglycan and collagen in cartilage in rheumatoid arthritis. J Bone Joint Surg Am 1978;60A: 349-54.
36. Blanco FJ, Guitian R, Vázquez -Martul E, de Toro FJ, Galdo F. Osteoarthritis chondrocytes die by apoptosis: a possible pathway for osteoarthritis pathology. Arthritis Rheum 1998;41: 284-9.
37. Adams CS, Horton WE. Chondrocyte apoptosis increases with age in the articular cartilage of adult animals. Anat Rec 1998;250:418-25.
38. Hashimoto S, Takahashi K, Amiel D, Coutts RD, Lotz M. Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis. Arthritis Rheum 1998;41:1266-74.
39. Van der Kraan PM, Vitters EL, van Beuningen HM, van den Berg WB. Proteoglycan synthesis and osteophyte formation in 'metabolically' and 'mechanically' induced murine degenerative joint disease: an in-vivo autoradiographic study. Int J Exp Pathol 1992;73:335-50.
40. Kafienah W, Brömme D, Buttle DJ, Croucher LJ, Hollander AP. Human cathepsin k cleaves native type I and II collagens at the n-terminal end of the triple helix. Biochem J 1998;331:727-32.